Treatment

Phase II trial of XPro1595 for the treatment of Alzheimer’s disease

Viral-mediated gene therapy for neurodegenerative disease

Improving the precision and safety of CRISPR/Cas genome editing

EXERT: why was strength/balance training as effective as cardio in preventing cognitive decline?

How does exercise affect cognition?

The neurogenesis hypothesis: NA-831 for the treatment of Alzheimer’s disease

Investigating CT1812: an S2R modulator in development for Alzheimer’s disease

Progress in the Davos Alzheimer’s Collaborative’s Global Cohort Development program

Investigational S2R modulator CT1812 affects key proteins in Alzheimer’s disease

The Davos Alzheimer’s Collaborative

Using digital technology to build a truly global cohort in Alzheimer’s disease

Phase II study of S2R modulation in patients with dementia with Lewy bodies

TOGETHER study: updates on bepranemab as a potential treatment for AD

Next steps in VCID research: molecular targets and fluid biomarkers

I-CONECT: effect of online conversations on psychosocial wellbeing in older adults

Buntanetap mechanism of action